A Study of Icatibant for Acute Attacks of Hereditary Angioedema in Japanese Participants

Summary

The objective of this study is to evaluate the efficacy, pharmacokinetics (PK), and safety of icatibant for the treatment of acute attacks in Japanese participants with type I or type II hereditary angioedema (HAE).

Timeline

Start

2015-03-18

Primary completion

2016-02-12

Completion

2016-02-12

Drugs

Indications